The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
High-dose ifosfamide (HDI) in metastatic synovial sarcoma: The Institut Gustave Roussy experience.
Arslane Skander Rahal
No relevant relationships to disclose
Angela Cioffi
No relevant relationships to disclose
Chahinez Rahal
No relevant relationships to disclose
Julien Domont
No relevant relationships to disclose
Aurore Blesius
No relevant relationships to disclose
Anna Patrikidou
No relevant relationships to disclose
Sylvie Bonvalot
No relevant relationships to disclose
C├ęcile Le Pechoux
No relevant relationships to disclose
Philippe Terrier
No relevant relationships to disclose
Laurence Vilcot
No relevant relationships to disclose
Emilie Lanoy
No relevant relationships to disclose
Axel Le Cesne
Honoraria - Novartis; Pfizer; PharmaMar